agilon health (NYSE:AGL) Now Covered by Needham & Company LLC

Stock analysts at Needham & Company LLC began coverage on shares of agilon health (NYSE:AGL) in a research note issued to investors on Friday,Briefing.com Automated Import reports. The brokerage set a “hold” rating on the stock.

A number of other research analysts have also weighed in on AGL. Sanford C. Bernstein initiated coverage on agilon health in a report on Wednesday, December 11th. They issued a “market perform” rating and a $2.50 price objective on the stock. TD Cowen dropped their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Citigroup cut their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Finally, Barclays reduced their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health has a consensus rating of “Hold” and an average target price of $3.98.

agilon health Stock Performance

Shares of AGL stock opened at $2.21 on Friday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market cap of $910.56 million, a PE ratio of -2.35 and a beta of 0.53. agilon health has a 12-month low of $1.50 and a 12-month high of $9.30. The business’s fifty day simple moving average is $2.07 and its 200-day simple moving average is $3.79.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the company earned ($0.06) EPS. Analysts expect that agilon health will post -0.52 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 90,000 shares of company stock worth $198,100. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Hedge funds have recently bought and sold shares of the stock. Citigroup Inc. grew its position in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares in the last quarter. AQR Capital Management LLC increased its stake in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after buying an additional 1,083,492 shares during the last quarter. Quantbot Technologies LP acquired a new position in shares of agilon health in the 3rd quarter valued at $1,742,000. Finally, Susquehanna Fundamental Investments LLC raised its stake in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.